Literature DB >> 21763327

Selective ablation of mu-opioid receptor expressing neurons in the rostral ventromedial medulla attenuates stress-induced mechanical hypersensitivity.

Jacques Reynolds1, Edward J Bilsky, Ian D Meng.   

Abstract

AIMS: Chronic stress-related conditions are often associated with stress-induced hyperalgesia. However, the neural circuitry responsible for producing stress-induced hyperalgesia is not well characterized. The aim of this study was to determine the contribution of mu-opioid expressing brainstem neurons to the expression of stress-induced hyperalgesia. MAIN
METHODS: The present study utilized a model of stress-induced mechanical hypersensitivity that involved application of repeated, light tactile whisker pad stimulation (WPS) in rats. Repeated WPS (10 applications/session, 4 sessions/h in 1 day, sessions on days 1-5 and 8-12) increased defensive-aggressive and hypervigilant behaviors, and produced hypersensitivity to tactile stimulation of the hind paw. In order to test the possible involvement of mu-opioid receptor expressing neurons in the rostral ventral medulla (RVM) to this response, rats received RVM microinjections of the toxin conjugate dermorphin-saporin or its control, saporin. Fourteen days later rats underwent either WPS or sham conditioning. KEY
FINDINGS: Repeated WPS produced defensive-aggressive behaviors directed towards the stimulus and mechanical hypersensitivity of the hind paw that persisted for up to 2 weeks after the final WPS session. Dermorphin-saporin, but not saporin, microinjections prevented the development of hind paw mechanical hypersensitivity, but did not affect the defensive-aggressive behaviors. SIGNIFICANCE: The finding that chronic stress produces mechanical hypersensitivity through circuitry that involves the RVM provides a potential neurobiological basis for the complex interaction between chronic stress and pain.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763327     DOI: 10.1016/j.lfs.2011.06.024

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  Ablation of μ opioid receptor-expressing GABA neurons in rostromedial tegmental nucleus increases ethanol consumption and regulates ethanol-related behaviors.

Authors:  Rao Fu; Xing Chen; Wanhong Zuo; Jing Li; Seungwoo Kang; Li-Hua Zhou; Allan Siegel; Alex Bekker; Jiang-Hong Ye
Journal:  Neuropharmacology       Date:  2016-02-24       Impact factor: 5.250

2.  The dorsomedial hypothalamus mediates stress-induced hyperalgesia and is the source of the pronociceptive peptide cholecystokinin in the rostral ventromedial medulla.

Authors:  K M Wagner; Z Roeder; K Desrochers; A V Buhler; M M Heinricher; D R Cleary
Journal:  Neuroscience       Date:  2013-02-13       Impact factor: 3.590

3.  Estrogen status and psychophysical stress modify temporomandibular joint input to medullary dorsal horn neurons in a lamina-specific manner in female rats.

Authors:  Keiichiro Okamoto; Randall Thompson; Ayano Katagiri; David A Bereiter
Journal:  Pain       Date:  2013-03-15       Impact factor: 6.961

4.  Anxiety-induced hyperalgesia in female rats is mediated by cholecystokinin 2 receptor in rostral ventromedial medulla and spinal 5-hydroxytryptamine 2B receptor.

Authors:  Ming Jiang; Jinhua Bo; Yishan Lei; Fan Hu; Zhengrong Xia; Yue Liu; Cui'e Lu; Yu'e Sun; Bailing Hou; Kun Ni; Zhengliang Ma; Xiaoping Gu
Journal:  J Pain Res       Date:  2019-07-03       Impact factor: 3.133

5.  Alterations in the rostral ventromedial medulla after the selective ablation of μ-opioid receptor expressing neurons.

Authors:  Ichiro Harasawa; Joshua P Johansen; Howard L Fields; Frank Porreca; Ian D Meng
Journal:  Pain       Date:  2016-01       Impact factor: 7.926

6.  Descending controls modulate inflammatory joint pain and regulate CXC chemokine and iNOS expression in the dorsal horn.

Authors:  Fiona B Carr; Sandrine M Géranton; Stephen P Hunt
Journal:  Mol Pain       Date:  2014-06-20       Impact factor: 3.395

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.